Development of a preclinical monkey model for iPSC-based T cell immunotherapy

被引：0
|
作者：
Iriguchi, Shoichi [1 ]
Miyake, Yasuyuki [1 ]
Miura, Tomoyuki [2 ]
Tachikawa, Ai [3 ]
Ueda, Tatsuki [1 ]
Taya, Kahoru
Imai, Eri [1 ]
Ishii, Hiroshi [3 ]
Onoe, Hirotaka
Matano, Tetsuro [3 ]
Kaneko, Shin [1 ]
机构：
[1] Kyoto Univ, CiRA, Kyoto, Japan
[2] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan
[3] Natl Inst Infect Dis, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Immune cell therapy; T cell;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1035
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [31] Human iPSC-Based Model of COPD to Investigate Disease Mechanisms, Predict SARS-COV-2 Outcome, and Test Preventive Immunotherapy
    Dagher, Rania
    Moldobaeva, Aigul
    Gubbins, Elise
    Clark, Sydney
    Madel Alfajaro, Mia
    Wilen, Craig B.
    Hawkins, Finn
    Qu, Xiaotao
    Chien Chiang, Chia
    Li, Yang
    Clarke, Lori
    Ikeda, Yasuhiro
    Brown, Charles
    Kolbeck, Roland
    Ma, Qin
    Rojas, Mauricio
    Koff, Jonathan L.
    Ghaedi, Mahboobe
    STEM CELLS, 2024, 42 (03) : 230 - 250
  • [32] For the establishment of iPSC based allogeneic T-cell immunotherapy against tumor.
    Atustaka, Minagawa
    Uemura, Yasushi
    Nakatsura, Tetsuya
    Yasukawa, Masaki
    Takasu, Naoko
    Yamanaka, Shinya
    Kaneko, Shin
    CANCER SCIENCE, 2018, 109 : 962 - 962
  • [33] iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests
    Themeli, Maria
    Chhatta, Amiet
    Boersma, Hester
    Prins, Henk Jan
    Cordes, Martijn
    de Wilt, Edwin
    Farahani, Aida Shahrabi
    Vandekerckhove, Bart
    van der Burg, Mirjam
    Hoeben, Rob C.
    Staal, Frank J. T.
    Mikkers, Harald M. M.
    STEM CELL REPORTS, 2020, 14 (02): : 300 - 311
  • [34] Development of iPSC-based models to test microglia-directed gene therapy for neurodegeneration
    Nubie', M.
    Hruska-Plochan, M.
    Gatta, B.
    Polymenidou, M.
    Raimondi, F.
    Pastukhov, O.
    Wrona, D.
    Jinek, M.
    Greter, M.
    Modlich, U.
    Siler, U.
    Reichenbach, J.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A134 - A135
  • [35] Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases
    Luciani, Marco
    Gritti, Angela
    Meneghini, Vasco
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [36] Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy
    Dagmara Grot
    Katarzyna Wasiak
    Jerzy Tyszkowski
    Ewelina Stoczynska-Fidelus
    Tomasz P. Ochedalski
    Piotr Rieske
    Stem Cell Research & Therapy, 13
  • [37] Genetic Correction of Phospholamban Mutation in an iPSC-Based Disease Model of Familial Dilated Cardiomyopathy
    Nonnenmacher, Mathieu E.
    Karakikes, Ioannis
    Stillitano, Francesca
    Weber, Thomas
    Hajjar, Roger J.
    MOLECULAR THERAPY, 2014, 22 : S193 - S193
  • [38] Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy
    Grot, Dagmara
    Wasiak, Katarzyna
    Tyszkowski, Jerzy
    Stoczynska-Fidelus, Ewelina
    Ochedalski, Tomasz P.
    Rieske, Piotr
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [39] Using human iPSC-based forebrain cortical organoids to model in utero exposure to dolutegravir
    Zhang, Daniel
    Demeng, Jeriel
    Temsamrit, Brian
    Jordan-Sciutto, Kelly
    Song, Hongjun
    Ming, Guo-li
    Christian, Kimberly
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (SUPPL 1) : S47 - S47
  • [40] iPSC-BASED IMMUNOTHERAPY DIFFERENTIATION PLATFORM ENABLES FEEDER-FREE EXPANSION OF NK CELLS TO CLINICAL SCALE
    Terheyden-Keighley, D.
    Hiller, B.
    Gamerschlag, A.
    Greber, B.
    CYTOTHERAPY, 2024, 26 (06) : S198 - S199
12345